{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T01:04:29Z","timestamp":1772759069327,"version":"3.50.1"},"reference-count":173,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.jaip.2013.11.005","type":"journal-article","created":{"date-parts":[[2014,1,6]],"date-time":"2014-01-06T15:15:53Z","timestamp":1389021353000},"page":"21-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Fever, Rash, and Systemic Symptoms: Understanding the Role of Virus and HLA in Severe Cutaneous Drug Allergy"],"prefix":"10.1016","volume":"2","author":[{"given":"Rebecca","family":"Pavlos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Mallal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Ostrov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuri","family":"Pompeu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2013.11.005_bib1","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/clpt.2011.30","article-title":"The phenotype standardization project: improving pharmacogenetic studies of serious adverse drug reactions","volume":"89","author":"Pirmohamed","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaip.2013.11.005_bib2","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/bjd.12502","article-title":"Systemic involvement of acute generalized exanthematous pustulosis: a retrospective study on 58 patients","volume":"169","author":"Hotz","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2013.11.005_bib3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1034\/j.1600-0560.2001.028003113.x","article-title":"Acute generalized exanthematous pustulosis (AGEP): a clinical reaction pattern","volume":"28","author":"Sidoroff","year":"2001","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.jaip.2013.11.005_bib4","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1684\/ejd.2010.0932","article-title":"Acute generalized exanthematous pustulosis: an overview of the clinical, immunological and diagnostic concepts","volume":"20","author":"Speeckaert","year":"2010","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaip.2013.11.005_bib5","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1684\/ejd.2013.2055","article-title":"\u201cCutaneous adverse drug reactions\u201d are not always drug-induced","volume":"23","author":"Raison-Peyron","year":"2013","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaip.2013.11.005_bib6","first-page":"487","article-title":"Acute generalized exanthematous pustulosis due to Coxsackie B4 virus [in Portuguese]","volume":"10","author":"Feio","year":"1997","journal-title":"Acta Med Port"},{"key":"10.1016\/j.jaip.2013.11.005_bib7","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1365-4362.1996.tb00653.x","article-title":"Acute generalized exanthematous pustulosis with cytomegalovirus infection","volume":"35","author":"Haro-Gabaldon","year":"1996","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaip.2013.11.005_bib8","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s00105-008-1604-1","article-title":"Acute generalized exanthematous pustulosis associated with recurrent urinary tract infections [in German with English abstract]","volume":"60","author":"Klein","year":"2009","journal-title":"Hautarzt"},{"key":"10.1016\/j.jaip.2013.11.005_bib9","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.arcped.2006.06.004","article-title":"Acute generalized exanthematous pustulosis: first case associated with a Chlamydia pneumoniae infection [in French with English abstract ]","volume":"13","author":"Manzano","year":"2006","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.jaip.2013.11.005_bib10","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0889-857X(05)70014-4","article-title":"Rheumatic manifestations of parvovirus B19 infection","volume":"24","author":"Naides","year":"1998","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.jaip.2013.11.005_bib11","first-page":"S38","article-title":"HLA et pr\u00e9disposition g\u00e9n\u00e9tique dans les pustuloses exanth\u00e9matiques aigu\u00ebs g\u00e9n\u00e9ralis\u00e9es (PEAG) et dans les exanth\u00e8mes maculo-papuleux (EMP)","volume":"122","author":"Bernard","year":"1995","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.jaip.2013.11.005_bib12","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1346-8138.2010.01176.x","article-title":"New aspects of drug-induced hypersensitivity syndrome","volume":"38","author":"Tohyama","year":"2011","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.jaip.2013.11.005_bib13","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/j.1365-2133.2007.08167.x","article-title":"Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome","volume":"157","author":"Tohyama","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2013.11.005_bib14","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.2217\/pgs.12.108","article-title":"HLA and pharmacogenetics of drug hypersensitivity","volume":"13","author":"Pavlos","year":"2012","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jaip.2013.11.005_bib15","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00002030-200501030-00014","article-title":"Predisposition to nevirapine hypersensitivity associated with HLA-DRB1*0101 and abrogated by low CD4 T-cell counts","volume":"19","author":"Martin","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.jaip.2013.11.005_bib16","unstructured":"Phillips EBJ, Sanne I, Lederman M, Hinkle J, Rousseau F, James I, et\u00a0al. Associations between HLA-DRBA*0102, HLA-B*5801 and hepatotoxicity in patients who initiated nevirapine containing regimens in South Africa. 18th Conference on retroviruses and opportunistic infections. Paper #949. Boston, MA; February 2011."},{"key":"10.1016\/j.jaip.2013.11.005_bib17","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1097\/QAD.0b013e32834779df","article-title":"Toxicogenomics of nevirapine-associated cutaneous and hepatic adverse events among populations of African, Asian, and European descent","volume":"25","author":"Yuan","year":"2011","journal-title":"AIDS"},{"key":"10.1016\/j.jaip.2013.11.005_bib18","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1097\/QAI.0b013e31827ca50f","article-title":"Associations between HLA-DRB1*0102, HLA-B*5801, and hepatotoxicity during initiation of nevirapine-containing regimens in South Africa","volume":"62","author":"Phillips","year":"2013","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jaip.2013.11.005_bib19","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1097\/01.aids.0000238408.82947.09","article-title":"HLA-dependent hypersensitivity to nevirapine in Sardinian HIV patients","volume":"20","author":"Littera","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.jaip.2013.11.005_bib20","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/QAD.0b013e32801199d9","article-title":"HLA-Cw8 primarily associated with hypersensitivity to nevirapine","volume":"21","author":"Gatanaga","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.jaip.2013.11.005_bib21","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1089\/aid.2011.0107","article-title":"HLA-dependent hypersensitivity reaction to nevirapine in chinese han hiv-infected patients","volume":"28","author":"Gao","year":"2011","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.jaip.2013.11.005_bib22","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/cid\/cit021","article-title":"Association of human leukocyte antigen alleles and nevirapine hypersensitivity in a Malawian HIV-infected population","volume":"56","author":"Carr","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaip.2013.11.005_bib23","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1345\/aph.1E202","article-title":"Updated clinical risk factor analysis of suspected hypersensitivity reactions to abacavir","volume":"38","author":"Cutrell","year":"2004","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jaip.2013.11.005_bib24","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0149-2918(02)85132-3","article-title":"Risk factor analysis of hypersensitivity reactions to abacavir","volume":"24","author":"Symonds","year":"2002","journal-title":"Clin Ther"},{"key":"10.1016\/j.jaip.2013.11.005_bib25","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0140-6736(02)08158-8","article-title":"Genetic variations in HLA-B region and hypersensitivity reactions to abacavir","volume":"359","author":"Hetherington","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2013.11.005_bib26","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0140-6736(02)07873-X","article-title":"Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir","volume":"359","author":"Mallal","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2013.11.005_bib27","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/01.aids.0000171414.99409.fb","article-title":"Clinical and immunogenetic correlates of abacavir hypersensitivity","volume":"19","author":"Phillips","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.jaip.2013.11.005_bib28","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1056\/NEJMoa0706135","article-title":"HLA-B*5701 screening for hypersensitivity to abacavir","volume":"358","author":"Mallal","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2013.11.005_bib29","unstructured":"Phillips ESS, Arribas J, Fitch N, Givens N. Characteristics of abacavir hypersensitivity diagnoses according to HLA-B*5701 status and subsequent abacavir patch test result. 11th European AIDS Conference. Madrid, Spain. 2007:P9.7\/04."},{"key":"10.1016\/j.jaip.2013.11.005_bib30","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1086\/529382","article-title":"High sensitivity of human leukocyte antigen-b*5701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patients","volume":"46","author":"Saag","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaip.2013.11.005_bib31","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/clpt.2011.355","article-title":"Clinical pharmacogenetics implementation consortium guidelines for HLA-B genotype and abacavir dosing","volume":"91","author":"Martin","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaip.2013.11.005_bib32","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/00008571-200406000-00002","article-title":"Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity","volume":"14","author":"Hughes","year":"2004","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.jaip.2013.11.005_bib33","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1097\/QAD.0b013e3283103ce6","article-title":"The cost-effectiveness of HLA-B*5701 genetic screening to guide initial antiretroviral therapy for HIV","volume":"22","author":"Schackman","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.jaip.2013.11.005_bib34","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1097\/00002030-200211080-00017","article-title":"Utility of patch testing in patients with hypersensitivity syndromes associated with abacavir","volume":"16","author":"Phillips","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.jaip.2013.11.005_bib35","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1177\/135965350801300202","article-title":"Cytokine profiling in abacavir hypersensitivity patients","volume":"13","author":"Almeida","year":"2008","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jaip.2013.11.005_bib36","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1097\/QAD.0b013e3280119579","article-title":"Immune responses to abacavir in antigen-presenting cells from hypersensitive patients","volume":"21","author":"Martin","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.jaip.2013.11.005_bib37","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.immuni.2008.04.020","article-title":"Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity","volume":"28","author":"Chessman","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.jaip.2013.11.005_bib38","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/428486a","article-title":"Medical genetics: a marker for Stevens-Johnson syndrome","volume":"428","author":"Chung","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.jaip.2013.11.005_bib39","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/01.fpc.0000199500.46842.4a","article-title":"Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions","volume":"16","author":"Hung","year":"2006","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.jaip.2013.11.005_bib40","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1533-2500.2011.00479.x","article-title":"HLA-B*1502 Strongly predicts carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Thai patients with neuropathic pain","volume":"12","author":"Kulkantrakorn","year":"2011","journal-title":"Pain Pract"},{"key":"10.1016\/j.jaip.2013.11.005_bib41","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1742-6405-6-22","article-title":"HLA-Cw*04 allele associated with nevirapine-induced rash in HIV-infected Thai patients","volume":"6","author":"Likanonsakul","year":"2009","journal-title":"AIDS Res Ther"},{"key":"10.1016\/j.jaip.2013.11.005_bib42","doi-asserted-by":"crossref","first-page":"579","DOI":"10.4103\/0378-6323.57718","article-title":"Association of HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians","volume":"75","author":"Mehta","year":"2009","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.jaip.2013.11.005_bib43","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1528-1167.2010.02533.x","article-title":"Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population","volume":"51","author":"Tassaneeyakul","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.jaip.2013.11.005_bib44","first-page":"290","article-title":"Frequency of the HLA-B*1502 allele contributing to carbamazepine-induced hypersensitivity reactions in a cohort of Malaysian epilepsy patients","volume":"29","author":"Then","year":"2011","journal-title":"Asian Pac J Allergy Immunol"},{"key":"10.1016\/j.jaip.2013.11.005_bib45","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.eplepsyres.2011.08.010","article-title":"Carbamazepine-induced severe cutaneous adverse reactions and HLA genotypes in Koreans","volume":"97","author":"Kim","year":"2011","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.jaip.2013.11.005_bib46","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1056\/NEJMoa1009717","article-title":"Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan","volume":"364","author":"Chen","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2013.11.005_bib47","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/clpt.2013.55","article-title":"HLA-A 31:01 and HLA-B 15:02 as genetic markers for carbamazepine hypersensitivity in children","volume":"94","author":"Amstutz","year":"2013","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaip.2013.11.005_bib48","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJMoa1013297","article-title":"HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans","volume":"364","author":"McCormack","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2013.11.005_bib49","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/hmg\/ddq537","article-title":"Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in a Japanese population","volume":"20","author":"Ozeki","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jaip.2013.11.005_bib50","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.jaci.2011.08.013","article-title":"Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome","volume":"128","author":"Ko","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2013.11.005_bib51","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0300-483X(00)00397-8","article-title":"Metabolic activation in drug allergies","volume":"158","author":"Park","year":"2001","journal-title":"Toxicology"},{"key":"10.1016\/j.jaip.2013.11.005_bib52","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2332\/allergolint.55.17","article-title":"Pharmacological interaction of drugs with immune receptors: the p-i concept","volume":"55","author":"Pichler","year":"2006","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaip.2013.11.005_bib53","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nature11147","article-title":"Immune self-reactivity triggered by drug-modified HLA-peptide repertoire","volume":"486","author":"Illing","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jaip.2013.11.005_bib54","doi-asserted-by":"crossref","first-page":"9959","DOI":"10.1073\/pnas.1207934109","article-title":"Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire","volume":"109","author":"Ostrov","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaip.2013.11.005_bib55","doi-asserted-by":"crossref","first-page":"F21","DOI":"10.1097\/QAD.0b013e328355fe8f","article-title":"Abacavir induces loading of novel self-peptides into HLA-B*57: 01: an autoimmune model for HLA-associated drug hypersensitivity","volume":"26","author":"Norcross","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.jaip.2013.11.005_bib56","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.jaci.2011.12.990","article-title":"Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome","volume":"129","author":"Wei","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2013.11.005_bib57","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1001\/archderm.140.2.183","article-title":"Association between anticonvulsant hypersensitivity syndrome and human herpesvirus 6 reactivation and hypogammaglobulinemia","volume":"140","author":"Kano","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaip.2013.11.005_bib58","first-page":"301","article-title":"Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms","volume":"137","author":"Descamps","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaip.2013.11.005_bib59","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2133.2006.07238.x","article-title":"Several herpesviruses can reactivate in a severe drug-induced multiorgan reaction in the same sequential order as in graft-versus-host disease","volume":"155","author":"Kano","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2013.11.005_bib60","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1365-2133.2006.07332.x","article-title":"Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome","volume":"155","author":"Seishima","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2013.11.005_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2332\/allergolint.55.1","article-title":"Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses","volume":"55","author":"Shiohara","year":"2006","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaip.2013.11.005_bib62","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001116","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response","volume":"2","author":"Picard","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaip.2013.11.005_bib63","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jaad.2012.10.017","article-title":"Short- and long-term outcomes of 34 patients with drug-induced hypersensitivity syndrome in a single institution","volume":"68","author":"Ushigome","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2013.11.005_bib64","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1046\/j.1365-2133.2001.04239.x","article-title":"Anticonvulsant hypersensitivity syndrome associated with reactivation of cytomegalovirus","volume":"144","author":"Aihara","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2013.11.005_bib65","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1046\/j.1365-2133.2003.05330.x","article-title":"Drug-induced hypersensitivity syndrome associated with Epstein-Barr virus infection","volume":"148","author":"Descamps","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2013.11.005_bib66","doi-asserted-by":"crossref","first-page":"411","DOI":"10.5694\/mja12.10477","article-title":"Severe drug-induced hypersensitivity syndrome with a shared HLA-B allele","volume":"197","author":"Harding","year":"2012","journal-title":"Med J Aust"},{"key":"10.1016\/j.jaip.2013.11.005_bib67","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000187619","article-title":"Systemic lupus erythematosus presenting with Kikuchi-Fujimoto's disease as a long-term sequela of drug-induced hypersensitivity syndrome. A possible role of Epstein-Barr virus reactivation","volume":"218","author":"Aota","year":"2009","journal-title":"Dermatology"},{"key":"10.1016\/j.jaip.2013.11.005_bib68","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.jaad.2005.03.057","article-title":"Fulminant type 1 diabetes mellitus caused by drug hypersensitivity syndrome with human herpesvirus 6 infection","volume":"54","author":"Chiou","year":"2006","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2013.11.005_bib69","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/j.1365-2133.2007.07784.x","article-title":"Sclerodermoid graft-versus-host disease-like lesions occurring after drug-induced hypersensitivity syndrome","volume":"156","author":"Kano","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2013.11.005_bib70","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1001\/jama.285.9.1153","article-title":"Rapid loss of insulin secretion in a patient with fulminant type 1 diabetes mellitus and carbamazepine hypersensitivity syndrome","volume":"285","author":"Sekine","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2013.11.005_bib71","doi-asserted-by":"crossref","first-page":"8071","DOI":"10.4049\/jimmunol.0804002","article-title":"Defective regulatory T cells in patients with severe drug eruptions: timing of the dysfunction is associated with the pathological phenotype and outcome","volume":"182","author":"Takahashi","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2013.11.005_bib72","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jaad.2012.08.009","article-title":"Long-term sequelae of drug reaction with eosinophilia and systemic symptoms: a retrospective cohort study from Taiwan","volume":"68","author":"Chen","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2013.11.005_bib73","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1084\/jem.179.4.1155","article-title":"An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease","volume":"179","author":"Burrows","year":"1994","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaip.2013.11.005_bib74","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1097\/01.TP.0000131158.81346.64","article-title":"Cross-reactivity of cytomegalovirus-specific CD8+ T cells to allo-major histocompatibility complex class I molecules","volume":"77","author":"Gamadia","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.jaip.2013.11.005_bib75","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1182\/blood.V99.10.3844","article-title":"Herpes simplex virus type 2-specific CD8 cytotoxic T lymphocyte cross-reactivity against prevalent HLA class I alleles","volume":"99","author":"Koelle","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2013.11.005_bib76","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.4049\/jimmunol.177.3.1427","article-title":"EBV-specific CD4+ T cell clones exhibit vigorous allogeneic responses","volume":"177","author":"Landais","year":"2006","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2013.11.005_bib77","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1182\/blood-2009-07-234906","article-title":"Allo-HLA reactivity of virus-specific memory T cells is common","volume":"115","author":"Amir","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2013.11.005_bib78","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.trim.2010.12.001","article-title":"Screening of viral specific T-cell lines for HLA alloreactivity prior to adoptive immunotherapy may prevent GvHD","volume":"24","author":"D'Orsogna","year":"2011","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.jaip.2013.11.005_bib79","doi-asserted-by":"crossref","first-page":"e12120","DOI":"10.1371\/journal.pone.0012120","article-title":"Cross-reactivity of herpesvirus-specific CD8 T cell lines toward allogeneic class I MHC molecules","volume":"5","author":"Morice","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2013.11.005_bib80","doi-asserted-by":"crossref","first-page":"6733","DOI":"10.1182\/blood-2011-05-354787","article-title":"Allo-HLA-reactive T cells inducing graft-versus-host disease are single peptide specific","volume":"118","author":"Amir","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2013.11.005_bib81","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1399-0012.1998.tb00971.x","article-title":"Epithelial- and endothelial-cell specificity of renal graft infiltrating T cells","volume":"12","author":"Deckers","year":"1998","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jaip.2013.11.005_bib82","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/ndt\/9.7.805","article-title":"Recognition of a tissue-specific polymorphism by graft infiltrating T-cell clones isolated from a renal allograft with acute rejection","volume":"9","author":"Yard","year":"1994","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jaip.2013.11.005_bib83","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/00007890-199707150-00034","article-title":"Tissue-specific characteristics of cytotoxic graft-infiltrating T cells during renal allograft rejection","volume":"64","author":"Deckers","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.jaip.2013.11.005_bib84","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/TP.0b013e318207944c","article-title":"Tissue specificity of cross-reactive allogeneic responses by EBV EBNA3A-specific memory T cells","volume":"91","author":"D'Orsogna","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.jaip.2013.11.005_bib85","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.jaci.2013.04.013","article-title":"HLA-B*57:01(+) abacavir-naive individuals have specific T cells but no patch test reactivity","volume":"132","author":"Schnyder","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2013.11.005_bib86","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.4049\/jimmunol.1102719","article-title":"Maintenance of T cell function in the face of chronic antigen stimulation and repeated reactivation for a latent virus infection","volume":"188","author":"Mackay","year":"2012","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2013.11.005_bib87","doi-asserted-by":"crossref","first-page":"8077","DOI":"10.4049\/jimmunol.0801117","article-title":"Inflation and long-term maintenance of CD8 T cells responding to a latent herpesvirus depend upon establishment of latency and presence of viral antigens","volume":"183","author":"Lang","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2013.11.005_bib88","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.4049\/jimmunol.1100666","article-title":"Functional CD8 T cell memory responding to persistent latent infection is maintained for life","volume":"187","author":"Lang","year":"2011","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2013.11.005_bib89","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1182\/blood-2009-05-220087","article-title":"The CD8+ memory T-cell state of readiness is actively maintained and reversible","volume":"114","author":"Allam","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2013.11.005_bib90","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/ni806","article-title":"T\u00a0cell immunodominance and maintenance of memory regulated by unexpectedly cross-reactive pathogens","volume":"3","author":"Brehm","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaip.2013.11.005_bib91","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1084\/jem.174.5.969","article-title":"T\u00a0cell memory is short-lived in the absence of antigen","volume":"174","author":"Gray","year":"1991","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaip.2013.11.005_bib92","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1750-1172-6-52","article-title":"Genome-wide association study of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe","volume":"6","author":"Genin","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jaip.2013.11.005_bib93","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1073\/pnas.0409500102","article-title":"HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol","volume":"102","author":"Hung","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaip.2013.11.005_bib94","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/FPC.0b013e3282f3ef9c","article-title":"A\u00a0European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs","volume":"18","author":"Lonjou","year":"2008","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.jaip.2013.11.005_bib95","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1471-2350-12-118","article-title":"Association of HLA-B*5801 allele and allopurinol-induced Stevens Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis","volume":"12","author":"Somkrua","year":"2011","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.jaip.2013.11.005_bib96","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/FPC.0b013e328330a3b8","article-title":"Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population","volume":"19","author":"Tassaneeyakul","year":"2009","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.jaip.2013.11.005_bib97","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1744-313X.2011.01011.x","article-title":"A\u00a0study of HLA class I and class II 4-digit allele level in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"38","author":"Cristallo","year":"2011","journal-title":"Int J Immunogenet"},{"key":"10.1016\/j.jaip.2013.11.005_bib98","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/FPC.0b013e32834282b8","article-title":"Positive and negative associations of HLA class I alleles with allopurinol-induced SCARs in Koreans","volume":"21","author":"Kang","year":"2011","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.jaip.2013.11.005_bib99","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s40264-013-0084-0","article-title":"Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012","volume":"36","author":"Ramasamy","year":"2013","journal-title":"Drug Saf"},{"key":"10.1016\/j.jaip.2013.11.005_bib100","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/bjd.12389","article-title":"HLA-B*58:01 is a risk factor for allopurinol-induced DRESS and Stevens-Johnson syndrome\/toxic epidermal necrolysis in a Portuguese population","volume":"169","author":"Goncalo","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2013.11.005_bib101","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1111\/j.1528-1167.2008.01719.x","article-title":"Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population","volume":"49","author":"Locharernkul","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.jaip.2013.11.005_bib102","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/j.1528-1167.2007.01022.x","article-title":"Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese","volume":"48","author":"Man","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.jaip.2013.11.005_bib103","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.seizure.2011.02.003","article-title":"Association between HLA-B*1502 allele and carbamazepine-induced severe cutaneous adverse reactions in Han people of southern China mainland","volume":"20","author":"Wang","year":"2011","journal-title":"Seizure"},{"key":"10.1016\/j.jaip.2013.11.005_bib104","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.yebeh.2010.08.007","article-title":"Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B*1502 allele among patients in central China","volume":"19","author":"Wu","year":"2010","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.jaip.2013.11.005_bib105","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00228-011-1009-4","article-title":"Strong association between HLA-B*1502 and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in mainland Han Chinese patients","volume":"67","author":"Zhang","year":"2011","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jaip.2013.11.005_bib106","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-4632.2010.04745.x","article-title":"Association of HLA-B*1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population","volume":"50","author":"Chang","year":"2011","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaip.2013.11.005_bib107","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/jamadermatol.2013.4114","article-title":"Relationship between the HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis","volume":"149","author":"Tangamornsuksan","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaip.2013.11.005_bib108","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1111\/epi.12217","article-title":"HLA-B alleles associated with severe cutaneous reactions to antiepileptic drugs in Han Chinese","volume":"54","author":"Cheung","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.jaip.2013.11.005_bib109","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1111\/j.1528-1167.2010.02766.x","article-title":"HLA-B*1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients","volume":"51","author":"Kaniwa","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.jaip.2013.11.005_bib110","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1528-1167.2009.02269.x","article-title":"HLA class I markers in Japanese patients with carbamazepine-induced cutaneous adverse reactions","volume":"51","author":"Ikeda","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.jaip.2013.11.005_bib111","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1346-8138.2011.01457.x","article-title":"HLA-A31 strongly associates with carbamazepine-induced adverse drug reactions but not with carbamazepine-induced lymphocyte proliferation in a Japanese population","volume":"39","author":"Niihara","year":"2011","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.jaip.2013.11.005_bib112","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2217\/pgs.09.162","article-title":"Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese","volume":"11","author":"Hung","year":"2010","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jaip.2013.11.005_bib113","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.eplepsyres.2010.10.006","article-title":"Association study of lamotrigine-induced cutaneous adverse reactions and HLA-B*1502 in a Han Chinese population","volume":"92","author":"An","year":"2010","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.jaip.2013.11.005_bib114","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1742-7843.2011.00681.x","article-title":"Hla-B alleles and lamotrigine-induced cutaneous adverse drug reactions in the Han Chinese population","volume":"109","author":"Shi","year":"2011","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.jaip.2013.11.005_bib115","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.2217\/pgs.13.180","article-title":"Specific HLA types are associated with antiepileptic drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese subjects","volume":"14","author":"Kaniwa","year":"2013","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jaip.2013.11.005_bib116","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1001\/archderm.1987.01660330082014","article-title":"Genetic susceptibility to toxic epidermal necrolysis","volume":"123","author":"Roujeau","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaip.2013.11.005_bib117","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00198-008-0677-0","article-title":"Strontium ranelate-induced toxic epidermal necrolysis in a patient with post-menopausal osteoporosis","volume":"20","author":"Lee","year":"2009","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jaip.2013.11.005_bib118","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00198-009-1097-5","article-title":"Treatment of osteoporosis: recognizing and managing cutaneous adverse reactions and drug-induced hypersensitivity","volume":"21","author":"Musette","year":"2010","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jaip.2013.11.005_bib119","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.2217\/14622416.9.11.1617","article-title":"HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"9","author":"Kaniwa","year":"2008","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jaip.2013.11.005_bib120","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/tpj.2011.41","article-title":"A\u00a0whole-genome association study of major determinants for allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients","volume":"13","author":"Tohkin","year":"2011","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.jaip.2013.11.005_bib121","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1365-2133.2012.10894.x","article-title":"Association between HLA-B*58:01 allele and severe cutaneous adverse reactions with allopurinol in Han Chinese in Hong Kong","volume":"167","author":"Chiu","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2013.11.005_bib122","unstructured":"Phillips E, Keane N, Blyth C, Lucas A, Pavlos R, Lucas M, et\u00a0al. Both HLA Class I restricted CD8+ and class II restricted CD4+ T cells are implicated in the pathogenesis of nevirapine hypersensitivity. 51st ICAAC. Chicago, Ill; September 2011:H1-1399c."},{"key":"10.1016\/j.jaip.2013.11.005_bib123","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2217\/14622416.7.6.813","article-title":"HLA-B locus in Caucasian patients with carbamazepine hypersensitivity","volume":"7","author":"Alfirevic","year":"2006","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jaip.2013.11.005_bib124","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1212\/WNL.56.7.890","article-title":"TNF alpha promoter region gene polymorphisms in carbamazepine-hypersensitive patients","volume":"56","author":"Pirmohamed","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jaip.2013.11.005_bib125","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1398-9995.2009.01940.x","article-title":"Strontium ranelate-induced DRESS syndrome: first two case reports","volume":"64","author":"Jonville-Bera","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2013.11.005_bib126","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1056\/NEJMoa1213096","article-title":"HLA-B*13:01 and the dapsone hypersensitivity syndrome","volume":"369","author":"Zhang","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2013.11.005_bib127","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/QAD.0b013e3282f37812","article-title":"HLA-DRB1*01 associated with cutaneous hypersensitivity induced by nevirapine and efavirenz","volume":"22","author":"Vitezica","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.jaip.2013.11.005_bib128","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/FPC.0b013e32831d0faf","article-title":"HLA-B*3505 allele is a strong predictor for nevirapine-induced skin adverse drug reactions in HIV-infected Thai patients","volume":"19","author":"Chantarangsu","year":"2009","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.jaip.2013.11.005_bib129","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/cid\/cir403","article-title":"Genome-wide association study identifies variations in 6p21.3 associated with nevirapine-induced rash","volume":"53","author":"Chantarangsu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaip.2013.11.005_bib130","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S1081-1206(10)62997-3","article-title":"Delayed hypersensitivity to aminopenicillins is related to major histocompatibility complex genes","volume":"80","author":"Romano","year":"1998","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2013.11.005_bib131","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.seizure.2010.11.014","article-title":"Pilot association study of oxcarbazepine-induced mild cutaneous adverse reactions with HLA-B*1502 allele in Chinese Han population","volume":"20","author":"Hu","year":"2011","journal-title":"Seizure"},{"key":"10.1016\/j.jaip.2013.11.005_bib132","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1471-2377-13-75","article-title":"The association between oxcarbazepine-induced maculopapular eruption and HLA-B alleles in a northern Han Chinese population","volume":"13","author":"Lv","year":"2013","journal-title":"BMC Neurol"},{"key":"10.1016\/j.jaip.2013.11.005_bib133","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S0016-5085(99)70404-X","article-title":"HLA association of amoxicillin-clavulanate\u2013induced hepatitis","volume":"117","author":"Hautekeete","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2013.11.005_bib134","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1053\/j.gastro.2011.04.001","article-title":"Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles","volume":"141","author":"Lucena","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2013.11.005_bib135","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1136\/gut.47.5.717","article-title":"Co-amoxiclav jaundice: clinical and histological features and HLA class II association","volume":"47","author":"O'Donohue","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.jaip.2013.11.005_bib136","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/ng.632","article-title":"A\u00a0genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury","volume":"42","author":"Singer","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaip.2013.11.005_bib137","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/sj.tpj.6500458","article-title":"Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis","volume":"8","author":"Kindmark","year":"2008","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.jaip.2013.11.005_bib138","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1053\/j.gastro.2006.11.023","article-title":"Genetic susceptibility to diclofenac-induced hepatotoxicity: contribution of UGT2B7, CYP2C8, and ABCC2 genotypes","volume":"132","author":"Daly","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2013.11.005_bib139","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1055\/s-0029-1240009","article-title":"Genetic association studies in drug-induced liver injury","volume":"29","author":"Daly","year":"2009","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jaip.2013.11.005_bib140","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3109\/03602532.2011.605790","article-title":"Genetic association studies in drug-induced liver injury","volume":"44","author":"Daly","year":"2012","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.jaip.2013.11.005_bib141","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ng.379","article-title":"HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin","volume":"41","author":"Daly","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaip.2013.11.005_bib142","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1200\/JCO.2010.31.3197","article-title":"HLA-DQA1*02:01 is a major risk factor for lapatinib-induced hepatotoxicity in women with advanced breast cancer","volume":"29","author":"Spraggs","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaip.2013.11.005_bib143","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0190-9622(94)70007-9","article-title":"Genetic susceptibility to fixed drug eruption: evidence for a link with HLA-B22","volume":"30","author":"Pellicano","year":"1994","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2013.11.005_bib144","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0190-9622(97)80347-7","article-title":"Fixed drug eruptions with feprazone are linked to HLA-B22","volume":"36","author":"Pellicano","year":"1997","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2013.11.005_bib145","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1067\/mjd.2001.117854","article-title":"Fixed drug eruption induced by trimethoprim-sulfamethoxazole: evidence for a link to HLA-A30 B13 Cw6 haplotype","volume":"45","author":"Ozkaya-Bayazit","year":"2001","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2013.11.005_bib146","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1001\/archpsyc.1990.01810220061007","article-title":"HLA-B38, DR4, DQw3 and clozapine-induced agranulocytosis in Jewish patients with schizophrenia","volume":"47","author":"Lieberman","year":"1990","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jaip.2013.11.005_bib147","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1365-2370.1998.00091.x","article-title":"HLA-B38 and clozapine-induced agranulocytosis in Israeli Jewish schizophrenic patients","volume":"25","author":"Valevski","year":"1998","journal-title":"Eur J Immunogenet"},{"key":"10.1016\/j.jaip.2013.11.005_bib148","doi-asserted-by":"crossref","first-page":"458","DOI":"10.4088\/JCP.09m05527yel","article-title":"Candidate gene analysis identifies a polymorphism in HLA-DQB1 associated with clozapine-induced agranulocytosis","volume":"72","author":"Athanasiou","year":"2011","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.jaip.2013.11.005_bib149","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/sj.tpj.6500423","article-title":"Clozapine-induced agranulocytosis in schizophrenic Caucasians: confirming clues for associations with human leukocyte class I and II antigens","volume":"7","author":"Dettling","year":"2007","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.jaip.2013.11.005_bib150","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/0167-5699(90)90109-M","article-title":"HLA-B27 and agranulocytosis by levamisole","volume":"11","author":"Diez","year":"1990","journal-title":"Immunol Today"},{"key":"10.1016\/j.jaip.2013.11.005_bib151","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(80)91554-8","article-title":"Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility","volume":"I","author":"Batchelor","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2013.11.005_bib152","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00403-008-0895-5","article-title":"Drug-induced lupus erythematosus","volume":"301","author":"Vedove","year":"2009","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaip.2013.11.005_bib153","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2217\/14622416.9.1.85","article-title":"Pharmacogenetics of aspirin-intolerant asthma","volume":"9","author":"Kim","year":"2008","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jaip.2013.11.005_bib154","first-page":"41","article-title":"Association of HLA-DR5 with mucocutaneous lesions in patients with rheumatoid arthritis receiving gold sodium thiomalate","volume":"21","author":"Rodriguez-Perez","year":"1994","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.jaip.2013.11.005_bib155","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1399-0039.1985.tb00932.x","article-title":"HLA associations in aurothioglucose- and D-penicillamine-induced haematotoxic reactions in rheumatoid arthritis","volume":"26","author":"Speerstra","year":"1985","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jaip.2013.11.005_bib156","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0091-6749(99)70243-5","article-title":"Association of HLA-DR11 with the anaphylactoid reaction caused by nonsteroidal anti-inflammatory drugs","volume":"103","author":"Quiralte","year":"1999","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2013.11.005_bib157","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1136\/bmj.286.6375.1442-a","article-title":"HLA antigens and acetylcholine receptor antibodies in penicillamine induced myasthenia gravis","volume":"286","author":"Garlepp","year":"1983","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.jaip.2013.11.005_bib158","first-page":"35","article-title":"HLA-A,-B, and -DR antigens in relation to gold and D-penicillamine toxicity in Greek patients with RA","volume":"4","author":"Pachoula-Papasteriades","year":"1986","journal-title":"Dis Markers"},{"key":"10.1016\/j.jaip.2013.11.005_bib159","doi-asserted-by":"crossref","first-page":"6910","DOI":"10.4049\/jimmunol.171.12.6910","article-title":"Influence of MHC class II in susceptibility to beryllium sensitization and chronic beryllium disease","volume":"171","author":"Maier","year":"2003","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2013.11.005_bib160","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/oem.2010.055046","article-title":"HLA class II DPB1 and DRB1 polymorphisms associated with genetic susceptibility to beryllium toxicity","volume":"68","author":"Rosenman","year":"2011","journal-title":"Occup Environ Med"},{"key":"10.1016\/j.jaip.2013.11.005_bib161","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1346-8138.2011.01365.x","article-title":"Drug eruption with eosinophilia and systemic syndrome associated with reactivation of human herpesvirus 7, not human herpesvirus 6","volume":"39","author":"Morito","year":"2012","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.jaip.2013.11.005_bib162","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1365-2133.1997.tb03795.x","article-title":"Human herpesvirus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive haemophagocytic syndrome","volume":"137","author":"Descamps","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2013.11.005_bib163","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jaad.2008.07.044","article-title":"Drug-induced hypersensitivity syndrome: drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome induced by aspirin treatment of Kawasaki disease","volume":"60","author":"Kawakami","year":"2009","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2013.11.005_bib164","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1365-4632.2009.04441.x","article-title":"Intractable genital ulcers from herpes simplex virus reactivation in drug-induced hypersensitivity syndrome caused by allopurinol","volume":"49","author":"Hamaguchi","year":"2010","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaip.2013.11.005_bib165","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1684\/ejd.2010.0821","article-title":"Amoxicillin-induced flare in patients with DRESS (drug reaction with eosinophilia and systemic symptoms): report of seven cases and demonstration of a direct effect of amoxicillin on Human Herpesvirus 6 replication in vitro","volume":"20","author":"Mardivirin","year":"2010","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaip.2013.11.005_bib166","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1365-4632.2007.03255.x","article-title":"DRESS syndrome caused by teicoplanin and vancomycin, associated with reactivation of human herpesvirus-6","volume":"46","author":"Tamagawa-Mineoka","year":"2007","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaip.2013.11.005_bib167","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-010348","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome secondary to antituberculosis drugs and associated with human herpes virus-7 (HHV-7)","author":"Draz","year":"2013","journal-title":"BMJ Case Rep. July 31,"},{"key":"10.1016\/j.jaip.2013.11.005_bib168","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.annder.2011.01.048","article-title":"Auto-immune thyroiditis and drug reaction with eosinophilia and systemic symptoms (DRESS) associated with HHV-6 viral reactivation [in French with English abstract]","volume":"138","author":"Funck-Brentano","year":"2011","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.jaip.2013.11.005_bib169","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2012-007558","article-title":"DRESS syndrome and thrombotic thrombocytopaenic purpura: are they related?","author":"Sandouk","year":"2012","journal-title":"BMJ Case Rep. November 14,"},{"key":"10.1016\/j.jaip.2013.11.005_bib170","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2340\/00015555-1014","article-title":"Strontium ranelate-induced DRESS syndrome with persistent autoimmune hepatitis","volume":"91","author":"Kinyo","year":"2011","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaip.2013.11.005_bib171","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.jbspin.2006.01.006","article-title":"DRESS syndrome induced by sulphasalazine in rheumatoid arthritis","volume":"73","author":"Bejia","year":"2006","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jaip.2013.11.005_bib172","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jbspin.2004.06.002","article-title":"DRESS syndrome in a patient on sulfasalazine for rheumatoid arthritis","volume":"72","author":"Michel","year":"2005","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jaip.2013.11.005_bib173","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2710.2009.01081.x","article-title":"DRESS-syndrome on sulfasalazine and naproxen treatment for juvenile idiopathic arthritis and reactivation of human herpesvirus 6 in an 11-year-old Caucasian boy","volume":"35","author":"Pinana","year":"2010","journal-title":"J\u00a0Clin Pharm Ther"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219813004522?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219813004522?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:07:14Z","timestamp":1761973634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219813004522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":173,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S2213219813004522"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2013.11.005","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fever, Rash, and Systemic Symptoms: Understanding the Role of Virus and HLA in Severe Cutaneous Drug Allergy","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2013.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}